• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于在无HIV-1辅助蛋白情况下安全、高效生产慢病毒载体的可诱导包装细胞系统。

An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.

作者信息

Pacchia A L, Adelson M E, Kaul M, Ron Y, Dougherty J P

机构信息

Department of Molecular Genetics and Microbiology, Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, New Jersey 08854, USA.

出版信息

Virology. 2001 Mar 30;282(1):77-86. doi: 10.1006/viro.2000.0787.

DOI:10.1006/viro.2000.0787
PMID:11259192
Abstract

Lentiviral vectors based on human immunodeficiency virus type 1 (HIV-1) possess the ability to deliver exogenous genes to both dividing and nondividing cells and to subsequently establish a stable provirus in these target cells, which can allow long-term expression of the transferred gene. Herein we describe a stable packaging cell line that is devoid of HIV-1 tat, vif, vpr, vpu, and nef. In order to avoid any risk of cytotoxicity associated with constitutive expression of HIV-1 protease or the VSV-G envelope protein, transcription of the packaging and envelope constructs was tightly controlled by employing the ecdysone-inducible system. Using this cell line, we have been able to consistently generate concentrated pseudotyped vector virus stocks with titers in the range of 10(8) IU/ml, which can efficiently transduce actively dividing and growth-arrested cells in vitro. This novel packaging cell line for lentiviral vectors facilitates the production of high-titer virus stocks in the absence of replication-competent virus and provides us with an important tool for use in future gene transfer studies.

摘要

基于1型人类免疫缺陷病毒(HIV-1)的慢病毒载体具有将外源基因传递至分裂细胞和非分裂细胞,并随后在这些靶细胞中建立稳定前病毒的能力,这能够使转移基因长期表达。在此,我们描述了一种稳定的包装细胞系,该细胞系缺乏HIV-1的tat、vif、vpr、vpu和nef基因。为了避免与HIV-1蛋白酶或VSV-G包膜蛋白的组成型表达相关的任何细胞毒性风险,通过采用蜕皮激素诱导系统严格控制包装和包膜构建体的转录。使用该细胞系,我们能够持续产生滴度在10(8)IU/ml范围内的浓缩假型载体病毒储备液,其能够在体外有效转导活跃分裂和生长停滞的细胞。这种用于慢病毒载体的新型包装细胞系有助于在无复制能力病毒的情况下生产高滴度病毒储备液,并为我们未来的基因转移研究提供了一个重要工具。

相似文献

1
An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.一种用于在无HIV-1辅助蛋白情况下安全、高效生产慢病毒载体的可诱导包装细胞系统。
Virology. 2001 Mar 30;282(1):77-86. doi: 10.1006/viro.2000.0787.
2
Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.用于长期大规模生产高滴度基于HIV-1的慢病毒载体的包装细胞系的构建
J Gene Med. 2005 Jun;7(6):818-34. doi: 10.1002/jgm.726.
3
Development of a novel trans-lentiviral vector that affords predictable safety.一种具有可预测安全性的新型转导慢病毒载体的开发。
Mol Ther. 2000 Jul;2(1):47-55. doi: 10.1006/mthe.2000.0095.
4
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.用于在体外和体内将基因传递到新生和成年心室心肌细胞的慢病毒载体。
Basic Res Cardiol. 2002 Sep;97(5):348-58. doi: 10.1007/s00395-002-0360-0.
5
Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.影响HIV-1衍生慢病毒载体对人CD34(+)细胞进行稳定转导的关键因素。
Mol Ther. 2000 Jul;2(1):71-80. doi: 10.1006/mthe.2000.0094.
6
RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.RD114 包膜蛋白为假型慢病毒载体提供了一种有效且通用的方法。
Exp Biol Med (Maywood). 2010 Oct;235(10):1269-76. doi: 10.1258/ebm.2010.010053. Epub 2010 Sep 27.
7
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells.源自猴免疫缺陷病毒(SIVmac251)的新型安全慢病毒载体的特性,该载体可有效转导成熟的人树突状细胞。
Gene Ther. 2000 Oct;7(19):1613-23. doi: 10.1038/sj.gt.3301292.
8
Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.1型人类免疫缺陷病毒感染长期存活者中vif、vpr和vpu序列的基因特征分析。
Virology. 1997 Feb 17;228(2):340-9. doi: 10.1006/viro.1996.8378.
9
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.通过慢病毒载体直接导入肝脏和肌肉的基因的持续表达。
Nat Genet. 1997 Nov;17(3):314-7. doi: 10.1038/ng1197-314.
10
Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.1型人类免疫缺陷病毒包膜糖蛋白YXXL内吞/极化信号对病毒辅助蛋白功能的影响
J Hum Virol. 2001 Sep-Oct;4(5):249-59.

引用本文的文献

1
From bench to bedside: the future of stable lentiviral packaging cell lines in gene therapy.从实验台到病床边:稳定慢病毒包装细胞系在基因治疗中的未来。
Gene Ther. 2025 Apr 26. doi: 10.1038/s41434-025-00537-6.
2
Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors.用于生产临床级慢病毒载体的稳定生产细胞系生成平台的建立与表征
Biomedicines. 2024 Oct 4;12(10):2265. doi: 10.3390/biomedicines12102265.
3
Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning.
使用异丙基苯甲酸和香豆霉素基因诱导系统以及纳米孔单细胞克隆技术产生慢病毒载体的包装细胞。
Mol Ther Methods Clin Dev. 2023 Feb 26;29:40-57. doi: 10.1016/j.omtm.2023.02.013. eCollection 2023 Jun 8.
4
Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.癌症基因治疗:慢病毒载体的基因治疗开发与生产。
Methods Mol Biol. 2022;2521:297-315. doi: 10.1007/978-1-0716-2441-8_16.
5
Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media.使用无血清培养基中生长的悬浮细胞生产慢病毒载体。
Mol Ther Methods Clin Dev. 2019 Nov 26;17:58-68. doi: 10.1016/j.omtm.2019.11.011. eCollection 2020 Jun 12.
6
Production of lentiviral vectors.慢病毒载体的生产。
Mol Ther Methods Clin Dev. 2016 Apr 13;3:16017. doi: 10.1038/mtm.2016.17. eCollection 2016.
7
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors.利用辅助依赖性腺病毒载体高效生产复制缺陷型人免疫缺陷病毒 1 型病毒载体颗粒。
Mol Ther Methods Clin Dev. 2015 Mar 18;2:15004. doi: 10.1038/mtm.2015.4. eCollection 2015.
8
RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.RD2-MolPack-Chim3,一种用于抗HIV基因治疗的慢病毒载体稳定生产的包装细胞系。
Hum Gene Ther Methods. 2013 Aug;24(4):228-40. doi: 10.1089/hgtb.2012.190. Epub 2013 Aug 3.
9
[Study on transduction of IL-24 gene in human bone marrow mesenchymal stem cells by lentiviral vector].慢病毒载体介导IL-24基因转染人骨髓间充质干细胞的研究
Zhongguo Fei Ai Za Zhi. 2013 Jan;16(1):7-11. doi: 10.3779/j.issn.1009-3419.2013.01.02.
10
Current translational and clinical practices in hematopoietic cell and gene therapy.当前在造血细胞和基因治疗中的转化和临床实践。
Cytotherapy. 2012 Aug;14(7):775-90. doi: 10.3109/14653249.2012.694420.